Success Story: An EB-1B Victory for a Medical Science Expert without RFE

Client’s Testimonial:

 

"Thank you very much for your email and for all your help throughout the EB1B process."

 


 

On May 4th, 2026, we received another EB-1B (Outstanding Professors and Researchers) approval for a Research Associate in the Field of Medical Science (Approval Notice).

 


 

General Field: Medical Science

 

Position at the Time of Case Filing: Research Associate

 

Approval Notice Date: May 4th, 2026

 

Processing Time: 13 months, 15 days

 


 

Case Summary:

 

"Without a doubt, [Client] has propelled the field of medical science research forward through exceptional prowess in unraveling the molecular mechanisms underlying this chronic skin condition."

 

This powerful endorsement came from one of four expert recommendation letters. Our expert team meticulously crafted a compelling petition on behalf of this accomplished medical science researcher, who holds an M.D. This remarkable EB-1B victory was achieved in over 13 months without an RFE.

 

Pioneering Research in Medical Science

 

This research addresses some of medicine's most pressing public health challenges, opening new avenues for novel therapeutic targets and improved patient outcomes. A strong background across multiple disciplines in medical science has enabled particularly original contributions, establishing a reputation as an outstanding researcher whose findings are actively relied upon by the global scientific community.

 

Strategic National Importance

 

The work carries significant relevance for the United States, where the conditions addressed by this research represent major public health and economic burdens. By advancing the understanding of disease mechanisms and developing more effective therapeutic strategies, these contributions directly support improved patient outcomes and reduced healthcare costs nationwide. With citations spanning institutions across six continents, the global reach of this research further ensures that American institutions remain at the forefront of progress in medical science.

 

Elite Recognition and Extraordinary Impact

 

  • Publishing Excellence: 34 peer-reviewed journal articles (2 first-authored and 3 co-first-authored)

 

  • Global Influence: 715 citations

 

  • Expert Authority: At least 57 peer reviews conducted for prestigious journals.

 

  • Funding Recognition: Research supported by two prominent national research funding bodies

 

Conclusion

 

This approval reflects the petition's compelling strength and the client's undeniable international standing in the field of medical science. We are honored to have supported this outstanding researcher throughout this journey and extend our sincerest best wishes for continued success and impactful contributions to psoriasis management and melanoma treatment in the United States.